─ Alma by ResQ Medical
ResQ Medical has completed a feasibility study with no device-related adverse events. The pivotal study is now enrolling, FDA IDE is approved, and commercial preparation is underway.
FDA IDE approved
Pivotal enrolling
Commercial preparation
underway